Israeli Pain Monitoring Startup Medasense Raises $18 Million
Summary
Israeli med-tech startup Medasense raised $18 million in a Series B round of funding. Medasense technology is the developer of an exclusive technology that objectively monitors and quantifies the patient’s pain response level using artificial intelligence algorithms and a proprietary noninvasive sensor platform. This new technology, which is currently used in operating rooms and critical care settings, where patients are under anesthesia and unable to communicate, enables clinicians to personalize treatment: control pain, avoid overdose, and eliminate doubt. “This funding round will allow us to expand and further consolidate commercial deployment of NOL technology in Europe through our distribution agreement with Medtronic and to complete the process of obtaining FDA approval for commercialization in the U.S.” Josep Ll. Its artificial intelligence solution is impacting clinical outcomes to benefit patients and to enable better use of healthcare resources.”
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
